Listen to ASX-listed Hastings Technology Metals’ COO, Andrew Reid talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s plan to muscle into the rare earths business that has been almost totally dominated by China in the past.

Listen to ASX-listed Australian Potash Managing Director, Matt Shackleton talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s plan to build a sulphate of potash fertiliser operation in WA that makes $124m a year.

Listen to ASX-listed Imugene Managing Director, Leslie Chong talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s cancer-fighting clinical trials that caused its market cap to jump from $12m to nearly a billion dollars.

Listen to ASX-listed Tietto Minerals’ Exec Director, Mark Strizek talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s plan to churn out over US$80m a year in free cash from its proposed African gold mine.

Listen to ASX-listed Cynata Therapeutics Managing Director, Dr Ross Macdonald talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s remarkable stem cell therapies and a long list of diseases it is looking to address with them.

Listen to ASX-listed Bardoc Gold CEO, Rob Ryan talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s plan to turn its 3m ounces of gold resources and 1m ounces of reserves into a gold mine – literally.